New approach to heart rate control as mortality reduction method in cardiac patients: potential of a new If inhibitor, ivabradine
Large-scale epidemiological studies have demonstrated that heart rate (HR) is an independent risk factor, increasing total, sudden and cardiovascular mortality risk. Ivabradine specifically binds to sinus node (SN) f-channels and reduces HR. Due to its specific SN action and selective If current inh...
Main Authors: | Yu. B. Belousov, O. A. Maneshina, S. B. Erofeeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2007-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1417 |
Similar Items
-
Ivabradine – a new agent for coronary heart disease treatment
by: O. A. Maneshina, et al.
Published: (2006-06-01) -
Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina
by: E. V. Kuleshova
Published: (2009-10-01) -
Coronary heart disease treatment: old principles and new horizons
by: Yu. A. Vasyuk, et al.
Published: (2007-02-01) -
Comparison of the safety and efficacy of ivabradine and nebivolol mono- and combination therapies in the treatment of stable angina pectoris patients with left ventricular dysfunction
by: Rasim Kutlu, et al.
Published: (2013-06-01) -
Beneficial effect of ivabradine against cardiovascular diseases
by: Maria Alessandra Gammone, et al.
Published: (2020-03-01)